POSC395 Pharmacoeconomic Analysis of rFVIIa Versus PCC in the Treatment of Minor-to-Moderate Bleeds in Hemophilia Patients with Inhibitors in China
Jan 1, 2022, 00:00
10.1016/j.jval.2021.11.1296
https://www.valueinhealthjournal.com/article/S1098-3015(21)03091-6/fulltext
Title :
POSC395 Pharmacoeconomic Analysis of rFVIIa Versus PCC in the Treatment of Minor-to-Moderate Bleeds in Hemophilia Patients with Inhibitors in China
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)03091-6&doi=10.1016/j.jval.2021.11.1296
First page :
Section Title :
Open access? :
No
Section Order :
10841